Organon & Co., headquartered in Jersey City, develops innovative health solutions in women’s health, biosimilars, and established brands, employing 10,000 people and operating six manufacturing facilities worldwide. The company went public on May 14, 2021, and offers products like Nexplanon and Follistim AQ through various distribution channels.
OGN has been in the news recently: Organon & Company has successfully acquired Dermavant Sciences to enhance its product offerings. This acquisition includes the FDA-approved VTAMA® cream, which is used for treating chronic skin conditions such as plaque psoriasis and atopic dermatitis.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
